Study casts doubt over lung cancer screening after overdiagnosing disease
This article was originally published in Clinica
A US study of over 7,000 patients has fuelled the debate over the value of screening for lung cancer, after reinforcing previous evidence that such a programme may lead to overdiagnosis of the disease.
You may also be interested in...
The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.
The guidance document allows manufacturers to promote their dry-heat systems for mask bioburden reduction if they meet certain standards.
The US Medicare agency is letting ambulatory surgical centers and patient homes be reimbursed as in-patient hospitals for patient care purposes during the pandemic.